Browse studies

Find your next paid study

27,370 recruiting studies available now

Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on early stage Parkinson's symptoms. VCR will be admin…

Parkinson Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

Stanford UniversityNCT05545826

Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients

The purpose of this research is to understand why some groups of people do not join clinical trials as much as others. These groups can include people from dif…

Pancreatic Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07591480

Phase 2

A Phase 2, Randomized, Double-blind, Placebo-controlled Pilot Study Assessing the Efficacy, Safety and Tolerability of Orally Administered BMS-986368, a FAAH/MAGL Inhibitor, for the Treatment of Spasticity in Participants With Post-stroke Spasticity

The goal of this clinical trial is to learn if the drug BMS-986368 works to treat post stroke spasticity in adults who have had a stroke. BMS-986368 is a desig…

Post-Stroke Spasticity

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Alberto EsquenaziNCT07704840

Phase 1

PRISM: Phase 1b of Retifanlimab and Ruxolitinib In Solid Malignancies Progressing on Prior Checkpoint Inhibition

The goal of this clinical trial is to learn what dose of ruxolitinib can be given safely together with retifanlimab in patients with metastatic renal cell carc…

Non Small Cell Lung CarcinomaRenal Cell Carcinoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of California, San DiegoNCT07219576

Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I)

A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided te…

TNBC - Triple-Negative Breast CancerMinimal Residual Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Personalis Inc.NCT06230185

Phase 4

Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting

The purpose of this study is to evaluate whether or not adding lumateparone to current antidepressant treatment in adults with major depressive disorder experi…

Blunted Emotion in Major Depressive Disorder

Estimated

~$25 – $1,400

Actual pay is set by the research site.

Future Options Research, LLCNCT07824206

Observational

Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation

Primary PC - or training HCT clinicians to deliver PC domains as part of routine practice - is an alternative model of supportive care. We have developed Senti…

Hematopoietic Cell TransplantHematologic Malignancy

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT06676852

Multi-Center Clinical Database of Infants for the Investigation of Early Nutrition Biomarkers

An observational study to generate a long-term outcome database from medical records for infants who completed protocol SS-101-18 or infants who are breastfed,…

Infant Development

Estimated

~$10 – $1,125

Actual pay is set by the research site.

ByHeartNCT05049655

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy in a Real-World Setting

The purpose of this study is to: * Describe the clinical characteristics of adult patients with transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-C…

Transthyretin Amyloidosis With Cardiomyopathy

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Alnylam PharmaceuticalsNCT07358078

Phase 2

Immuno-consolidation for Newly Diagnosed Multiple Myeloma Using Lack of MRD Negativity After Initial cOmbination Therapy to Pursue Deeper Responses With Linvoseltamab ANd Delay Transplant

The purpose of this study is to determine whether Linvoseltamab therapy in patients with newly diagnosed multiple myeloma will convert the disease status from …

Multiple Myeloma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Dickran Kazandjian, MDNCT06376526

Phase 1

Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

Rates of bacterial sexually transmitted infections (STIs) are rising globally, demanding innovative interventions beyond the scope of current efforts to preven…

Sexually Transmitted Diseases, Bacterial

Estimated

~$500 – $6,750

Actual pay is set by the research site.

University of California, San FranciscoNCT06414408

Phase 1

A Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-21447 (a Bcl-2 Inhibitor) Combinations for Patients With HR+/HER2- Metastatic Breast Cancer

This is a dose escalation and dose expansion study to assess the safety and tolerability of BGB-21447 (a B-cell leukemia/lymphoma 2 inhibitor, Bcl-2i) in combi…

Hormone-receptor-positive Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BeOne MedicinesNCT06756932